Serenex

PharmaceuticalsSeries DDurham, US

Latest round

Series D

Last raised

Jun 2007

Total raised

$67M

Investors

12

About Serenex

, is based in Durham, US and is an integrated drug discovery and development company, engages in the discovery and development of small molecule Hsp90 inhibitors.

Who invested in Serenex

12 investors across 5 rounds

See all investors in Serenex

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Jun 28, 2007

    Amount

    $12M

    Investors

    Locked

  2. Series C

    Oct 6, 2005

    Amount

    $30M

    Investors

    Locked

  3. Series B

    Aug 2, 2004

    Amount

    $8M

    Investors

    Locked

  4. Series B

    Aug 20, 2002

    Amount

    $15M

    Investors

    Locked

  5. Series A

    Jun 1, 2001

    Amount

    $2M

    Investors

    Locked

Questions about Serenex

Who invested in Serenex?

Serenex has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Serenex raised?

Serenex has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Serenex last raise money?

Serenex's most recent round on record is a Series D, in Jun 2007.

What does Serenex do?

, is based in Durham, US and is an integrated drug discovery and development company, engages in the discovery and development of small molecule Hsp90 inhibitors.

Where is Serenex headquartered?

Serenex is headquartered in Durham, US.

Which VCs invest in companies like Serenex?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Serenex's stage. Their profiles are linked below.

Raising like Serenex? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.